Keyphrases
Amyotrophic Lateral Sclerosis
100%
Clinical Impact
100%
Immune System
57%
Clinical Translation
14%
Neurodegenerative Diseases
14%
Pathogenic Mechanism
14%
Microbiota
14%
Sporadic Cases
14%
Cerebrospinal Fluid
14%
Pathophysiology
14%
Individualized Treatment
14%
Recent Advances
14%
Positron Emission Tomography
14%
Neuroinflammation
14%
Novel Therapeutic Targets
14%
Local Factors
14%
New Evidence
14%
Human Patients
14%
Systemic Factors
14%
Ongoing Clinical Trials
14%
Pathophysiologic Mechanisms
14%
Disease Biology
14%
System Involvement
14%
Medicine and Dentistry
Amyotrophic Lateral Sclerosis
100%
Immune System
57%
Diseases
28%
Clinical Trial
14%
Positron Emission Tomography
14%
Pathophysiology
14%
Cerebrospinal Fluid
14%
Neuroinflammation
14%
Degenerative Disease
14%
Hope
14%
Blood Group
14%
Immunology and Microbiology
Immune System
100%
Microflora
25%
Cerebrospinal Fluid
25%
Positron Emission Tomography
25%
Blood Group
25%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Diseases
28%
Clinical Trial
14%
Microflora
14%
Degenerative Disease
14%
Pathophysiology
14%
Nervous System Inflammation
14%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
In Vivo
14%
Neurodegenerative Disorder
14%
Positron Emission Tomography
14%